Behnam et al., 2015 - Google Patents
Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residueBehnam et al., 2015
- Document ID
- 5044675788084155103
- Author
- Behnam M
- Graf D
- Bartenschlager R
- Zlotos D
- Klein C
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
The dengue virus (DENV) and West Nile Virus (WNV) NS2B-NS3 proteases are attractive targets for the development of dual-acting therapeutics against these arboviral pathogens. We present the synthesis and extensive biological evaluation of inhibitors that contain …
- 241000710886 West Nile virus 0 title abstract description 196
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
- C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Behnam et al. | Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue | |
| Weigel et al. | Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors | |
| Shen et al. | Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity | |
| Steuten et al. | Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19 | |
| Nitsche et al. | Biochemistry and medicinal chemistry of the dengue virus protease | |
| Behnam et al. | C-terminal residue optimization and fragment merging: discovery of a potent peptide-hybrid inhibitor of dengue protease | |
| Nitsche et al. | Thiazolidinone–peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture | |
| Millies et al. | Proline-based allosteric inhibitors of Zika and Dengue virus NS2B/NS3 proteases | |
| Nitsche et al. | Peptide–boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology | |
| Stille et al. | Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors | |
| Nitsche | Proteases from dengue, West Nile and Zika viruses as drug targets | |
| DeGoey et al. | Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A | |
| Knox et al. | Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors | |
| Deng et al. | Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping | |
| Kühl et al. | A new class of dengue and West Nile virus protease inhibitors with submicromolar activity in reporter gene DENV-2 protease and viral replication assays | |
| Jacobs et al. | Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease | |
| Schüller et al. | Tripeptide inhibitors of dengue and West Nile virus NS2B–NS3 protease | |
| Goetz et al. | Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus | |
| Hammamy et al. | Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B–NS3 protease | |
| Li et al. | Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline | |
| Cregar-Hernandez et al. | Small molecule pan-dengue and West Nile virus NS3 protease inhibitors | |
| Chowdhury et al. | Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides | |
| Stoermer et al. | Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity | |
| Kühl et al. | Beyond basicity: discovery of nonbasic DENV-2 protease inhibitors with potent activity in cell culture | |
| Lai et al. | Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro |